Tenderskhoj
Germany
- Healthcare & Medical Medical
LOCATION SUMMARY DEADLINE
Germany Framework Agreement For The Delivery Of Wall Displays In Various Sizes
19 Jul 2024
Germany Jcp 2024.09 Measure Pursuant To Section 16 Para. 1 Sgb Ii In Conjunction With Section 45 Sgb Iii – Perspective And Energy Jcp 2024.09 Measure Pursuant To Section 16 Para. 1 Sgb Ii In Conjunction With Section 45 Sgb Iii – Perspective And Energy
10 Jul 2024
Germany Substitute Generics No. 21
09 Aug 2024
Germany Supply Of Reagents And Antibodies For Immunohistochemistry, Including Equipment Provision
26 Jul 2024
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Naloxegol, Atc A06ah03 (obo) For The Period 01.08.2024 - 31.07.2026
05 Jun 2026
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Albendazole, Atc P02ca03 (obg) For The Period 01.08.2024 - 31.07.2026
05 Jun 2026
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Clonazepam, Atc N03ae01 (obg) For The Period 01.08.2024 - 31.07.2026
05 Jun 2026
Germany Lot 1 Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Fesoterodine, Atc G04bd11 (obg) For The Period 01.08.2024 - 31.07.2026
05 Jun 2026
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Bimatoprost + Timolol (exclusively Edo), Atc S01ed62 (obo) For The Period 01.08.2024 - 31.07.2026
05 Jun 2026
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Olanzapine (excl. Dafo. For The Production Of A Depot - Isu, Atc N05ah03 (obo) For D. Z. 01.08.24 - 31.07.26
05 Jun 2026